Madison, Wis. — Researchers led by James Dahlberg, a founder of Madison-based bioscience company Third Wave Technologies, have found that a super-small genetic element may play a critical role in the development of certain types of cancer....
Milwaukee — There's no secret as to why the Madison area has developed a research-based economy to rival far larger U.S. cities....
From Burrill & Company's recent analysis, it would appear that 2004 was a very good year for biotech in almost all the financing categories....
After word leaked out, the Wall Street Journal detailed the news of another Japanese pharma merger. This signals that Japan is more willing to allow consolidation with foreign countries....
Madison, Wis. — Madison-based Third Wave Technologies this week reported the best annual financial results in the company's short history, wrapping up a year in which it met or exceeded all of its stated fiscal expectations....
A United Nations panel has fired yet another salvo into the human-cloning battle, which was punctuated recently by the UK's decision to allow therapeutic researchers to grow cloned embryos with up to around 200 cells....
One of the advantages of doing business in the Midwest is a significant cost advantage versus setting up shop in other parts of the country (or even the world)....
Madison, Wis. — Tackling a pressing and controversial technical barrier in stem cell biology, scientists at the WiCell Research Institute and the University of Wisconsin-Madison have crafted a recipe that allows researchers to grow human embryonic stem cells in the absence of mouse-derived "feeder" cells....
• WARF will receive the National Medal of Technology from President Bush
• Governor Doyle offers $5,000 award to a small business for tech-transfer achievement...
The British government has decided to allow the researcher who cloned Dolly the sheep to clone human embryos and produce stem cells. The focus of his research is similar to that of a UW-Madison scientist, Su-Chun Zhang....